Trade Moderna Inc ^MRNA

With Pseudoscience Reigning, Debunker Offers Tips For Fighting Back 06/05/2025

FDA Not Recommending Newly Approved COVID-19 Vaccine: Official | ZeroHedge

Case: Patents/Claim Construction (Fed. Cir.)

US appeals court sides with Moderna on COVID patent claims

Fed Circ upholds Moderna's COVID-19 vaccine win against Alnylam

Alnylam Fails to Revive Patent Infringement Suit Against Moderna

Pharma execs speak out: UK pricing rebates scare investors | BioWorld

Alpha Wealth Funds LLC Buys Shares of 15,000 Moderna, Inc. (NASDAQ:MRNA)

US Fed Circuit rules in favor of Moderna in patent squabble | BioWorld

HHS axes $776 million Moderna bird flu vaccine deal over safety, ethical concerns - NaturalNews.com

Moderna Will Test New Covid Shot Against Placebo, RFK Says (1)

Moderna's (MRNA) "Market Perform" Rating Reaffirmed at William Blair

LVW Advisors LLC Invests $298,000 in Moderna, Inc. (NASDAQ:MRNA)

How Moderna went From pandemic hero to vaccine victim

Moderna (MRNA) Faces Multiple Regulatory Challenges

Brad Miller Joins Keystone as President of CoreAI | Morningstar

Moderna Disables Comments On X Post Announcing New Covid Shot Amid Backlash | ZeroHedge

Douglas Lane & Associates LLC Buys 99,713 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna Shares Rise on FDA Approval of Covid-19 Vaccine | Morningstar

Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine | Fox News

Moderna Shares Gain On FDA Approval For New COVID-19 Vaccine

Analysts Conflicted on These Healthcare Names: CSPC Pharmaceutical Group (OtherCHJTF) and Moderna (MRNA) | Markets Insider

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19 | Markets Insider

CDC confirms ample supply of COVID-19 drugs, vaccines - Focus Taiwan

US FDA approves Moderna's new lower-dose Covid-19 vaccine 'mNexspike' | Health News - Business Standard

Moderna's new lower-dose COVID-19 vaccine approved by FDA

Investors Buy High Volume of Call Options on Moderna (NASDAQ:MRNA)

US approves new lower-dose COVID-19 vaccine made by Moderna

FDA Approves Moderna COVID Vaccine for Adults 65 or Older | Newsmax.com

HIV's Most Promising Breakthrough Has Taken a Hit

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by California State Teachers Retirement System

FDA Covid Update: Moderna's New mNEXSPIKE Vaccine Approved for Seniors

US approves new Moderna Covid jab for over-65s

Coronavirus Vaccine: New COVID vaccine approved by US FDA: Here's all about it | - Times of India

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older

US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | Morningstar

US authorities approve Moderna's new COVID vaccine - Statement

Moderna wins narrower US approval for new COVID vaccine | Health & Fitness | ArcaMax Publishing

HHS cancels funding for Moderna vaccines to fight pandemic flu

New COVID variant NB.1.8.1: New COVID variant NB.1.8.1 spreading fast in the U.S - is your vaccine effective? Will there be a summer surge? - The Economic Times

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript

Why is Trump's administration cutting bird flu vaccine funding? - CBS News

HHS axes $700M Moderna bird flu vaccine contract - is this a pivot to more dangerous, self-replicating mRNA jabs? - NaturalNews.com

Trump administration pulls bird flu, other vaccine funding awarded to Moderna

US ends $590 mn Moderna deal to develop bird flu vaccine using mRNA tech | World News - Business Standard

US cancels $766-M Moderna vaccine contract | The Manila Times

U.S. Ends $600M Moderna Bird Flu Vaccine Contract

US Cancels $700 Million Moderna Bird Flu Vaccine Contract

Trump administration cancels funding for Moderna bird flu vaccine

Trump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test results - CBS Minnesota

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update | Morningstar

US Cancels $590 Million Contract With Moderna for Bird Flu Shot | Newsmax.com

US cancels $590 million contract with Moderna for bird flu shot | The Manila Times

HHS terminating Moderna's $590M grant for flu vaccines | BioWorld

US cancels over $700mn funding for Moderna bird flu vaccine

US cancels US$590 million contract with Moderna for bird flu shot - CNA

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

US cancels $700m in funding for Moderna's bird flu vaccine

Trump administration cancels $766 million Moderna contract to fight pandemic flu

Moderna's $766 million pandemic flu vaccine contract canceled by Trump administration

Trump administration pulls the plug on the bird flu vaccine : NPR

HHS cuts funding to 'under-tested' mRNA technology for bird flu vaccines | Fox News

US Cancels $700M Funding for Moderna's Bird Flu Vaccine, Moderna to Explore Alternatives

Trump admin cancels $766m Moderna contract to fight pandemic flu

The New Legal Battle Over Trump's Sweeping Tariffs | The Fiscal Times

HHS cancels funding for Moderna to develop vaccines to combat bird flu

HHS to Terminate Moderna Late Stage Flu Vaccine Award | Morningstar

US cancels more than US$700 million funding for Moderna bird flu vaccine

HHS Cancels $766 Million in Funds for Moderna Bird Flu Shot (1)

Moderna confirms HHS to terminate flu vaccine award | Markets Insider

HHS to cancel nearly $600M Moderna flu vaccine contract, STAT reports | Markets Insider

U.S. Ends Funding For Moderna's Influenza Vaccine; Moderna Explores Alternatives For H5 Program

Assessing Your Talent Needs in the Age of AI

What is Zacks Research's Estimate for Moderna Q2 Earnings?

HHS cancels Moderna's $590 million contract for bird flu vaccine | News & Features | ArcaMax Publishing

CDC ends Covid vaccine recommendation for healthy kids and pregnant women

Moderna entities must face infringement suits, UPC rules

Moderna to Present at Upcoming Conferences in June 2025 | Morningstar

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Two Sigma Advisers LP

AI-Driven mRNA Therapeutics Market Development Accelerated by AI Integration in Drug Design Delivery and Scalable Manufacturing

Jim Cramer on Moderna (MRNA): "I've Been Against This Stock For So Long" - Insider Monkey

Moderna withdraws flu-COVID vaccine application amid heightened FDA scrutiny - NaturalNews.com

U.S. Senator on Trump: 'That was the emergency he came up with' | Watch News Videos Online

Carney is 'doing things a little differently' | Watch News Videos Online

Moderna's updated Covid vaccine for review | The Manila Times

JPMorgan Chase & Co. Lowers Moderna (NASDAQ:MRNA) Price Target to $26.00